NEW YORK (GenomeWeb) – OncoDNA announced today that it has signed an agreement under which its products will be marketed and distributed in Belarus by Shchurko.

The deal includes OncoDeep, a solid tumor test that uses NGS, FISH, immunohistochemistry, and other approaches; OncoTrace and OncoSelect liquid biopsy tests; OncoStrat&Go, which combines solid and liquid biopsies to help guide treatment decisions; and OncoKDM data interpretation and reporting software.

Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.